• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 3 Sep

    Abeona Therapeutics Announces Strategic Review

    Company engages Jefferies LLC in response to strategic inbound interest NEW YORK and CLEVELAND, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (ABEO), a fully-integrated leader in gene and cell therapy, today announced that it has retained Jefferies LLC as its financial advisor to assist with the review of… Read More..

    Share this:
  • 3 Sep

    Nephros Announces Presentations at Five Upcoming Investor Conferences

    SOUTH ORANGE, NJ, Sept. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced presentations at five upcoming investor conferences. Daron Evans, President and Chief Executive Officer, and… Read More..

    Share this:
  • 3 Sep

    Arch Therapeutics to Provide Corporate Update at the H.C. Wainwright 21st Annual Global Investment Conference

    FRAMINGHAM, Mass., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company at the H.C. Wainwright 21st Annual Global Investment Conference. The conference is being held on September… Read More..

    Share this:
« Previous 1 … 259 260 261 262 263 … 295 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact